Fortis Malar Hospitals (BSE 523696)₹44.90+4.18%Hospital
In the Jun 2026 quarter (consolidated), Fortis Malar Hospitals reported sales of ₹0 Cr, down 100.0% from Jun 2025, and net profit of ₹0.14 Cr, down 96.6% year on year. For the year to Mar 2026, sales were ₹0 Cr and net profit ₹4.13 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 18.16 | 17.59 | 5.53 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.00 | 0.00 | 0.00 |
| Expenses | 18.22 | 18.68 | 5.03 | 0.89 | 0.46 | 0.40 | 0.36 | 0.36 | 0.42 | 0.32 | 0.54 | 0.32 |
| Operating Profit | −0.07 | −1.08 | 0.47 | −0.87 | −0.46 | −0.40 | −0.36 | −0.32 | −0.37 | −0.32 | −0.54 | −0.32 |
| OPM % | −0.4% | −6.2% | 8.7% | — | — | — | — | −1,650.0% | −1,266.7% | — | — | — |
| Other Income | 2.32 | 1.27 | 59.79 | 0.84 | 0.57 | 0.57 | 0.78 | 4.62 | 0.53 | 0.53 | 0.67 | 0.54 |
| Interest | 1.31 | 1.27 | 0.40 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 2.73 | 2.92 | 1.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | −1.80 | −4.01 | 58.83 | −0.07 | 0.10 | 0.16 | 0.41 | 4.29 | 0.15 | 0.20 | 0.12 | 0.21 |
| Tax % | 0.0% | 0.3% | 8.0% | 0.0% | 0.0% | 93.4% | 10.0% | 3.1% | 92.9% | 89.5% | 136.4% | 25.1% |
| Exceptional items | 0.00 | 0.00 | 52.82 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | −1.78 | −3.99 | 54.00 | −0.05 | 0.08 | 0.00 | 0.35 | 4.14 | 0.00 | 0.01 | −0.04 | 0.14 |
| EPS (Rs) | −0.95 | −2.12 | 28.74 | −0.02 | 0.04 | 0.00 | 0.18 | 2.20 | 0.00 | 0.00 | −0.02 | 0.07 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 130 | 141 | 149 | 145 | 112 | 69.30 | 86.15 | 85.98 | 59.05 | 0.00 | 0.00 | 0.02 |
| Expenses | 123 | 140 | 147 | 147 | 115 | 75.54 | 82.77 | 81.40 | 60.19 | 2.13 | 1.61 | 1.60 |
| Operating Profit | 6.29 | 0.91 | 1.74 | −2.34 | −2.69 | −6.33 | 3.43 | 4.58 | −1.20 | −2.13 | −1.61 | −1.55 |
| OPM % | 4.9% | 0.7% | 1.2% | −1.6% | −2.4% | −9.2% | 4.0% | 5.3% | −2.0% | — | −3,140.1% | −7,750.0% |
| Other Income | 7.22 | 7.96 | 8.46 | 10.05 | 11.14 | 15.14 | 7.40 | 6.65 | 64.99 | 2.73 | 6.36 | 2.27 |
| Interest | 0.41 | 0.47 | 0.39 | 0.52 | 7.83 | 7.21 | 6.57 | 6.08 | 4.31 | 0.02 | 0.00 | 0.00 |
| Depreciation | 3.17 | 3.95 | 4.22 | 4.39 | 12.54 | 12.89 | 12.54 | 12.16 | 9.37 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 9.98 | 4.48 | 5.62 | 2.80 | −11.97 | −11.34 | −8.28 | −7.03 | 50.10 | 0.58 | 4.74 | 0.68 |
| Tax % | 35.6% | 30.2% | 40.6% | 26.2% | −25.4% | −30.4% | 0.1% | 121.0% | 9.4% | 31.6% | 12.5% | — |
| Exceptional items | −0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 6.98 | 0.00 | 0.00 | 52.82 | 0.00 | 0.00 | 0.00 |
| Net Profit | 6.41 | 3.10 | 3.31 | 2.05 | −8.88 | −7.86 | −8.26 | −15.47 | 45.27 | 0.38 | 4.13 | 0.11 |
| EPS (Rs) | 3.44 | 1.66 | 1.77 | 1.09 | −4.72 | −4.19 | −4.39 | −8.24 | 24.09 | 0.20 | 2.20 | 0.05 |
| Dividend payout % | 14.5% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 175.9% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 18.57 | 18.58 | 18.66 | 18.69 | 18.74 | 18.73 | 18.72 | 18.72 | 18.74 | 18.72 | 18.74 | 18.74 |
| Reserves | 72.73 | 79.25 | 81.07 | 84.61 | 86.87 | 77.83 | 70.09 | 61.46 | 45.56 | 90.84 | 11.48 | 15.63 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 64.40 | 57.16 | 53.41 | 46.49 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 19.58 | 32.39 | 30.99 | 45.86 | 45.25 | 32.64 | 23.07 | 27.24 | 27.30 | 6.38 | 6.63 | 3.25 |
| Total Liabilities | 111 | 130 | 131 | 149 | 151 | 194 | 169 | 161 | 138 | 116 | 36.85 | 37.62 |
| Fixed Assets | 17.70 | 24.49 | 24.58 | 23.78 | 21.84 | 81.03 | 68.50 | 57.60 | 47.40 | 0.00 | 0.00 | 0.00 |
| CWIP | 0.63 | 0.35 | 0.60 | 0.71 | 0.72 | 0.08 | 0.35 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 92.55 | 105 | 106 | 125 | 128 | 112 | 100 | 103 | 90.69 | 116 | 36.85 | 37.62 |
| Inventories | 0.99 | 2.60 | 2.30 | 2.01 | 1.64 | 1.30 | 1.62 | 1.85 | 1.09 | 0.00 | 0.00 | 0.00 |
| Trade receivables | 4.22 | 6.02 | 5.59 | 6.01 | 9.68 | 3.74 | 2.10 | 2.21 | 3.19 | 0.00 | 0.00 | 0.00 |
| Cash & equivalents | 18.66 | 25.34 | 7.66 | 14.72 | 6.66 | 43.36 | 13.59 | 12.57 | 9.46 | 108 | 17.83 | 24.76 |
| Total Assets | 111 | 130 | 131 | 149 | 151 | 194 | 169 | 161 | 138 | 116 | 36.85 | 37.62 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 4.40 | 10.49 | −8.60 | 8.80 | −16.00 | −0.31 | −0.87 | 6.85 | 5.62 | −7.31 | 1.55 | 0.63 |
| Cash from investing activity | 5.33 | −21.89 | 13.46 | −1.57 | 6.33 | 49.89 | −27.53 | 8.24 | 0.51 | 120 | −29.09 | 0.45 |
| Cash from financing activity | 0.00 | −1.08 | −0.96 | 0.04 | 0.14 | −11.53 | −7.23 | −10.07 | −12.62 | −10.82 | −79.37 | 0.00 |
| Net cash flow | 9.74 | −12.52 | 3.93 | 7.29 | −9.49 | 38.06 | −35.66 | 4.99 | −6.55 | 102 | −107 | 1.09 |
| Capex | 3.28 | 10.65 | 3.57 | 3.69 | 2.70 | 3.32 | 0.52 | 1.39 | 1.87 | 2.31 | 0.00 | 0.00 |
| Free cash flow | 1.10 | −0.09 | −12.10 | 5.09 | −18.63 | −3.19 | −1.38 | 5.54 | 3.72 | −9.57 | 1.53 | 0.61 |
| CFO / OP % | 132.9% | 235.0% | −175.1% | 801.0% | 458.0% | −143.0% | 204.0% | 219.9% | 120.9% | 188.0% | 81.0% | 51.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 13 | 17 | 14 | 15 | 24 | 12 | 11 | 9 | 14 | 0 | — | — |
| Inventory days | 13 | 35 | 28 | 22 | 18 | 22 | 42 | 40 | 32 | 0 | — | — |
| Days payable | 168 | 285 | 173 | 276 | 256 | 323 | 372 | 428 | 584 | — | — | — |
| Cash conversion cycle | −143 | −234 | −131 | −240 | −215 | −289 | −320 | −380 | −539 | 0 | — | — |
| Working capital days | 164 | 126 | 153 | 132 | 156 | −55 | 115 | 22 | 184 | −8 | — | — |
| ROCE % | 14.2% | 11.9% | 5.1% | 5.9% | 3.3% | −3.0% | −7.1% | −1.2% | −0.8% | −3.3% | 0.8% | 14.7% |
For the Jun 2026 quarter, Fortis Malar Hospitals reported sales of ₹0 Cr, down 100.0% year on year and net profit of ₹0.14 Cr, down 96.6% year on year.
Fortis Malar Hospitals' sales for the year to Mar 2026 were ₹0 Cr; over the last twelve months they were ₹0.02 Cr.
Net profit for the year to Mar 2026 was ₹4.13 Cr, and ₹0.11 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.05.
Fortis Malar Hospitals reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹24.76 Cr.
Cash from operations was ₹0.63 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0.61 Cr.